Qvella FAST System and FAST-PBC get CE marked and USFDA listed
With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods
With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods
Support for biologics manufacturability and Industry 4.0 initiatives
The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth
The main aim of the challenge is to encourage early-stage start-ups and individuals working on innovations in Ayurveda and other alternative healing and medicine systems
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features
Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
Subscribe To Our Newsletter & Stay Updated